Back

ACTIV-2/A5401

Official Title

A5401: Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID)

Study Details

The purpose of the study is to evaluate the safety and efficacy of different investigational medications for the treatment of symptomatic non-hospitalized adults with COVID-19.

Principal Investigator

Dr. Rachel Presti

IRB Number

202007121

Eligibility

1. Participants must be 18 years of age or older
2. Participants must have documentation of laboratory-confirmed SARS-CoV-2 infection
3. Participants must not be currently hospitalized or have previously been hospitalized for SARS-CoV-2 infection

Volunteer Information

For more information about this study, contact Volunteer for Health at:

Back